The current study evaluates the feasibility of a cancer prevention strategy using non-toxic MBZ alone and in combination with COX-2 inhibitors in a cis Nf1+/−;Tp53+/− (NPcis) mouse model of NF1 [21]. This evidence concerns the gene TP53 and cancer.